Erratum: Interaction of Saccharomyces boulardii with Salmonella enterica Serovar Typhimurium Protects Mice and Modifies T84 Cell Response to the Infection (PLOS ONE (2010) 5:1 (e8925) DOI: 10.1371/journal.pone.0008925PMID: 20111723);Interaction of Saccharomyces boulardii with Salmonella enterica serovar typhimurium protects mice and modifies T84 cell response to the infection

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Martins, Flaviano S ^a,c,f,g   Dalmasso, Guillaume ^a,c,h   Arantes, Rosa M E ^f   Doye, Anne ^b,c   Lemichez, Emmanuel ^b,c,d   Lagadec, Patricia ^a,c   Imbert, Veronique ^a,c   Peyron, Jean François ^a,c,d   Rampal, Patrick ^e   Nicoli, Jacques R ^f   Czerucka, Dorota ^a,c  

^a INSERM   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e CENTRE HOSPITALIER PRINCESSE GRACE   (Monaco)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g UNIVERSITY OF ALBERTA   (Canada)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PROBIOTIC AGENT; RAC1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CANCER CELL CULTURE; CELL DEATH; CELL INTERACTION; CELL INVASION; CELL STRAIN; CELL STRAIN T84; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFECTION PREVENTION; INFECTION RESISTANCE; INFLAMMATION; MOUSE; NONHUMAN; SACCHAROMYCES BOULARDII; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SIGNAL TRANSDUCTION; ANIMAL; BACTERIUM ADHERENCE; FREEZE DRYING; IMMUNOLOGY; LIVER; METABOLISM; MICROBIOLOGY; MORTALITY; PATHOGENICITY; PHYSIOLOGY; SACCHAROMYCES; SALMONELLOSIS; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIA (MICROORGANISMS); MUS; SACCHAROMYCES BOULARDII; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

ANIMALS; BACTERIAL ADHESION; FREEZE DRYING; LIVER; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROBIOTICS; SACCHAROMYCES; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SIGNAL TRANSDUCTION;

EID: 77952522194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0267067     Document Type: Erratum

References (32)

1. Galán JE, Bliska JB (1996) Cross-talk between bacterial pathogens and their host cells. Annu Rev Cell Dev Biol 12: 221-255.
2. Galán JE, Collmer A (1999) Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284: 1322-1328.
3. Wallis TS, Galyov EE (2000) Molecular basis of Salmonella-induced enteritis. Mol Microbiol 36: 997-1005.
4. Hobbie S, LM Chen LM, Davis RJ, Galán JE (1997) Involvement of mitogenactivated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol 159: 5550-5559.
5. Giannella RA (1979) Importance of the intestinal inflammatory reaction in Salmonella-mediated intestinal secretion. Infect Immun 23: 140-145.
6. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, et al. (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Biol Investig 95: 647-665.
7. McCormick BA, Colgan SP, Delp-Archer C, Miller SI, Madara JL (1993) Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signaling to subepithelial neutrophils. J Cell Biol 123: 895-907.
8. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855.
9. Mukaida N, Okamoto SI, Ishikawa Y, Matsushima K (1994) Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 56: 554-558.
10. FAO/WHO (2002) Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada.
11. Czerucka D, Piche T, Rampal P (2007) Review article: yeast as probiotics-Saccharomyces boulardii. Aliment Pharmacol Ther 26: 767-778.
12. Czerucka D, Rampal P (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4: 733-739.
13. Castagliuolo I, Lamont JT, Nikulasson ST, Pothoulakis C (1996) Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun 64: 5225-5232.
14. Pothoulakis C, Kelly CP, Joshi MA, Gao N, O'Keane CJ, et al. (1993) Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 104: 1108-1115.
15. Czerucka D, Roux I, Rampal P (1994) Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′, 5′-cyclic monophosphate induction in intestinal cells. Gastroenterology 106: 65-72.
16. Brandão RL, Castro IM, Bambirra EA, Amaral SC, Fietto LG, et al. (1999) Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol 64: 564-568.
17. Chen X, Kokkotou EG, Mustafa N, Bhaskar KR, Sougioultzis S, et al. (2006) Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo, and protects against Clostridium difficile toxin-induced enteritis. J Biol Chem 281: 24449-24459.
18. Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P (2000) Saccharomyces boulardii preserves the barrier function and modulates the transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68: 5998-6004.
19. Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, et al. (2003) Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71: 766-773.
20. Mumy KL, Chen X, Kelly CP, McCormick BA (2008) Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. Am J Physiol Gastrointest Liver Physiol 294: G599-G609.
21. Kornonen TK, Leffler H, Svanborg Eden C (1981) Binding specificity of piliated strains of Escherichia coli and Salmonella typhimurium to epithelial cells, Saccharomyces cerevisiae cells, and erythrocytes. Infect Immun 32: 796-804.
22. Doye A, Boyer L, Mettouchi A, Lemichez E (2002) Ubiquitin-mediated proteasomal degradation of Rho proteins by the CNF1 toxin. Meth Enzymol 406: 447-456.
23. Hopkins KL, Day M, Threlfall EJ (2008) Plasmid mediated quinolone resistance in Salmonella enterica. Emerg Infect Dis 14: 340-342.
24. Whichard JM, Gay K, Stevenson JE, Joyce KJ, Cooper KL, et al. (2007) Human Salmonella and concurrent decreased susceptibility to quinolones and extendedspectrum cephalosporins. Emerg Infect Dis 13: 1681-1688.
25. Rodrigues ACP, Nardi RM, Bambirra EA, Vieira EC, Nicoli JR (1996) Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J Appl Bacteriol 81: 251-256.
26. Jones BD, Falkow S (1996) Salmonellosis: host immune responses and bacterial virulence determinants. Ann Rev Immunol 14: 533-561.
27. Gedek BR (1999) Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42: 261-264.
28. Patel JC, Galan JE (2006) Differential activation and function of RhoGTPases during Salmonella-host cell interactions. J Cell Biol 175: 453-463.
29. Tran Van Nhieu G, Enninga J, Sansonetti P, Grompone G (2005) Tyrosine kinase signaling and type III effectors orchestrating Shigella invasion. Curr Opin Microbiol 8: 16-20.
30. Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, et al. (2006) Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343: 69-76.
31. National Research Council (1996) Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press .
32. Martins FS, Rodrigues ACP, Tiago FCP, Penna FJ, Rosa CA, et al. (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56: 352-359.